MHRA-100969-PIP01-23

Key Facts

Active Substance
Active Substance:
  • V940 (mRNA-4157), Modified messenger ribonucleic acid encoding individual patient-specific tumour neoantigens
Invented Name
Not available at present
PIP Number MHRA-100969-PIP01-23
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Dispersion for injection
Therapeutic area
Therapeutic area:
  • Oncology
Conditions / Indications
Conditions / Indications:
  • Treatment of lung cancer
Route(s) of administration
Route(s) of administration:
  • Intramuscular use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):V940 (mRNA-4157), Modified messenger ribonucleic acid encoding individual patient-specific tumour neoantigens.pdf
Published Date 30/04/2024